ALIVUS LIFE SCIENCES
Quarterly Results Analysis [Dec2024]
ALIVUS LIFE SCIENCES Quarterly Results
Standalone | Dec2024 UnAudited |
Sep2024 UnAudited |
Jun2024 UnAudited |
Mar2024 Audited |
Dec2023 Audited |
Sep2023 Audited |
Jun2023 UnAudited |
Mar2023 Audited |
---|---|---|---|---|---|---|---|---|
Revenues | ₹642 Cr | ₹507 Cr | ₹589 Cr | ₹537 Cr | ₹573 Cr | ₹595 Cr | ₹578 Cr | ₹621 Cr |
Expenses | ₹452 Cr | ₹373 Cr | ₹429 Cr | ₹395 Cr | ₹400 Cr | ₹428 Cr | ₹385 Cr | ₹415 Cr |
Operating Income | ₹190 Cr | ₹134 Cr | ₹159 Cr | ₹141 Cr | ₹173 Cr | ₹167 Cr | ₹193 Cr | ₹206 Cr |
Other Income | ₹10 Cr | ₹9 Cr | ₹5 Cr | ₹3 Cr | ₹2 Cr | ₹5 Cr | ₹2 Cr | ₹3 Cr |
Interest | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr |
Depreciation | ₹15 Cr | ₹15 Cr | ₹14 Cr | ₹15 Cr | ₹13 Cr | ₹13 Cr | ₹13 Cr | ₹12 Cr |
Profit Before Tax | ₹185 Cr | ₹127 Cr | ₹150 Cr | ₹130 Cr | ₹161 Cr | ₹159 Cr | ₹182 Cr | ₹198 Cr |
Profit After Tax | ₹137 Cr | ₹95 Cr | ₹111 Cr | ₹98 Cr | ₹119 Cr | ₹119 Cr | ₹135 Cr | ₹146 Cr |
EPS | ₹11.18 | ₹7.78 | ₹9.10 | ₹7.99 | ₹9.69 | ₹9.69 | ₹11.05 | ₹11.95 |
Industry Peers & Returns | 1W | 1M | 1Y |
ALIVUS LIFE SCIENCES | -0.2% | 13.9% | 35.2% |
SUN PHARMACEUTICAL INDUSTRIES | 2.3% | 11.7% | 5.1% |
DIVIS LABORATORIES | -1.6% | 4% | 58.7% |
CIPLA | 0.8% | 6.2% | -2.9% |
TORRENT PHARMACEUTICALS | 0.7% | 9.8% | 19.8% |
DR REDDYS LABORATORIES | -1% | 2.8% | -8% |
MANKIND PHARMA | -1.4% | 4.5% | 4.7% |
ZYDUS LIFESCIENCES | 1.1% | 3.5% | -10.8% |
LUPIN | 3.7% | 7.3% | 23.8% |
ALIVUS LIFE SCIENCES Quarterly Revenues
Revenues | |
---|---|
Q-o-Q | 26.63 % |
Y-o-Y | 12.05 % |
Quarters | Revenues | % Change | |
---|---|---|---|
Dec2024 | ₹642 Cr | 26.63 | |
Sep2024 | ₹507 Cr | -13.89 | |
Jun2024 | ₹589 Cr | 9.69 | |
Mar2024 | ₹537 Cr | -6.32 | |
Dec2023 | ₹573 Cr | -3.79 | |
Sep2023 | ₹595 Cr | 2.92 | |
Jun2023 | ₹578 Cr | -6.90 | |
Mar2023 | ₹621 Cr | - |
ALIVUS LIFE SCIENCES Quarterly Operating Profit
Operating Profit | |
---|---|
Q-o-Q | 41.64 % |
Y-o-Y | 10.29 % |
Quarters | Operating Profit | % Change | |
---|---|---|---|
Dec2024 | ₹190 Cr | 41.64 | |
Sep2024 | ₹134 Cr | -15.75 | |
Jun2024 | ₹159 Cr | 12.75 | |
Mar2024 | ₹141 Cr | -18.03 | |
Dec2023 | ₹173 Cr | 3.27 | |
Sep2023 | ₹167 Cr | -13.50 | |
Jun2023 | ₹193 Cr | -6.43 | |
Mar2023 | ₹206 Cr | - |
Operating Margins | |
---|---|
Q-o-Q | 11.84 % |
Y-o-Y | -1.56 % |
Quarters | Operating Margin% | % Change | |
---|---|---|---|
Dec2024 | 29.65% | 11.84 | |
Sep2024 | 26.51% | -2.14 | |
Jun2024 | 27.09% | 2.77 | |
Mar2024 | 26.36% | -12.48 | |
Dec2023 | 30.12% | 7.34 | |
Sep2023 | 28.06% | -15.96 | |
Jun2023 | 33.39% | 0.51 | |
Mar2023 | 33.22% | - |
ALIVUS LIFE SCIENCES Quarterly Profit After Tax
Profit After Tax(PAT) | |
---|---|
Q-o-Q | 43.69 % |
Y-o-Y | 15.32 % |
Quarters | Profit After Tax | % Change | |
---|---|---|---|
Dec2024 | ₹137 Cr | 43.69 | |
Sep2024 | ₹95 Cr | -14.50 | |
Jun2024 | ₹111 Cr | 13.83 | |
Mar2024 | ₹98 Cr | -17.54 | |
Dec2023 | ₹119 Cr | 0.02 | |
Sep2023 | ₹119 Cr | -12.34 | |
Jun2023 | ₹135 Cr | -7.45 | |
Mar2023 | ₹146 Cr | - |
PAT Margins | |
---|---|
Q-o-Q | 13.51 % |
Y-o-Y | 2.94 % |
Quarters | PAT Margin(%) | % Change | |
---|---|---|---|
Dec2024 | 21.34 % | 13.51 | |
Sep2024 | 18.8 % | -0.74 | |
Jun2024 | 18.94 % | 3.78 | |
Mar2024 | 18.25 % | -11.96 | |
Dec2023 | 20.73 % | 3.96 | |
Sep2023 | 19.94 % | -14.86 | |
Jun2023 | 23.42 % | -0.59 | |
Mar2023 | 23.56 % | - |
ALIVUS LIFE SCIENCES Quarterly Earnings Per Share (EPS)
EPS | |
---|---|
Q-o-Q | 43.70 % |
Y-o-Y | 15.38 % |
Quarters | EPS | % Change | |
---|---|---|---|
Dec2024 | ₹11.18 | 43.70 | |
Sep2024 | ₹7.78 | -14.51 | |
Jun2024 | ₹9.1 | 13.89 | |
Mar2024 | ₹7.99 | -17.54 | |
Dec2023 | ₹9.69 | 0.00 | |
Sep2023 | ₹9.69 | -12.31 | |
Jun2023 | ₹11.05 | -7.53 | |
Mar2023 | ₹11.95 | - |
You may also like the below Video Courses
SUN PHARMACEUTICAL INDUSTRIES LTD vs DIVIS LABORATORIES LTD vs CIPLA LTD
TORRENT PHARMACEUTICALS LTD vs DR REDDYS LABORATORIES LTD vs MANKIND PHARMA LTD